mhurhangee/ep-ind-claims huggingface dataset:
A process for manufacturing a coated ophthalmic lens comprising the steps of: curing a reactive monomer mix to form an ophthalmic lens, the reactive monomer mix comprising at least one latent reactive component in an amount effective to provide sufficient bonding sites for reaction with a coating composition, wherein the latent reactive component is at least one ester compound of the formula R-CO-L, wherein R comprises a group capable of cationic, anionic or free radical polymerisation and L is a leaving group, and reacting the ophthalmic lens with a coating composition in an amount sufficient to coat the surface of the ophthalmic lens, the coating composition comprising one or more nucleophilic moieties selected from the group consisting of alcohol, primary amine, secondary amine, thiol and combinations thereof to form the coated ophthalmic lens. curing a reactive monomer mix to form an ophthalmic lens, the reactive monomer mix comprising at least one latent reactive component in an amount effective to provide sufficient bonding sites for reaction with a coating composition, wherein the latent reactive component is at least one ester compound of the formula R-CO-L, wherein R comprises a group capable of cationic, anionic or free radical polymerisation and L is a leaving group, and reacting the ophthalmic lens with a coating composition in an amount sufficient to coat the surface of the ophthalmic lens, the coating composition comprising one or more nucleophilic moieties selected from the group consisting of alcohol, primary amine, secondary amine, thiol and combinations thereof to form the coated ophthalmic lens.
An inspection device for a rod-shaped smoking article, comprising: a plurality of light sources configured to generate light beams with different wavelength distributions; an adjuster configured to form an inspection beam from the light beams generated by the respective light sources; an irradiation unit configured to irradiate the rod-shaped smoking article with the inspection beam formed by the adjuster; a light receiver configured to receive a measurement beam that is obtained when the inspection beam applied from the irradiation unit acts on the rod-shaped smoking article; and a determination unit configured to determine quality of the rod-shaped smoking article based on the measurement beam received by the light receiver, wherein the adjuster is configured to adjust a color of the inspection beam by mixing the light beams generated by the respective light sources; wherein the adjuster is configured to adjust the color of the inspection beam by adjusting intensity of each of the light beams generated by the respective light sources; wherein the adjuster includes a coupler unit configured to couple the light beams generated by the respective light sources, an alignment unit configured to branch the light beam coupled by the coupler unit into a plurality of light beams, and a propagation section configured to propagate the light beams branched by the alignment unit to the irradiation unit. a plurality of light sources configured to generate light beams with different wavelength distributions; an adjuster configured to form an inspection beam from the light beams generated by the respective light sources; an irradiation unit configured to irradiate the rod-shaped smoking article with the inspection beam formed by the adjuster; a light receiver configured to receive a measurement beam that is obtained when the inspection beam applied from the irradiation unit acts on the rod-shaped smoking article; and a determination unit configured to determine quality of the rod-shaped smoking article based on the measurement beam received by the light receiver, wherein the adjuster is configured to adjust a color of the inspection beam by mixing the light beams generated by the respective light sources; wherein the adjuster is configured to adjust the color of the inspection beam by adjusting intensity of each of the light beams generated by the respective light sources; wherein the adjuster includes a coupler unit configured to couple the light beams generated by the respective light sources, an alignment unit configured to branch the light beam coupled by the coupler unit into a plurality of light beams, and a propagation section configured to propagate the light beams branched by the alignment unit to the irradiation unit.
Damping device provided with a first connecting member and a second connecting member which are capable of connecting said damping device to a first mechanical member and a second mechanical member, respectively, said damping device comprising a resilient member and a hydraulic system which are positioned between the first connecting member and the second connecting member, said hydraulic system comprising an outer casing containing a hydraulic fluid, said hydraulic system comprising a rod which can be translated relative to said outer casing, said rod extending longitudinally from a first end to a second end along a longitudinal axis, said rod having a projecting part that projects longitudinally from said outer casing, said first connecting member being reversibly fastened to the outer casing so as to be constrained to move in translation with the outer casing, said resilient member being arranged around said projecting part of the rod, said resilient member comprising at least one resilient means positioned between a first reinforcement and a second reinforcement, said first connecting member being reversibly fastened to the outer casing so as to be constrained to move in translation with the outer casing, the first reinforcement being reversibly fastened to said outer casing so as to be constrained to move in translation with the outer casing, the second reinforcement being constrained to move in translation with said projecting part, said second resilient member being reversibly fastened to said projecting part, characterised in that said outer casing is sealed, said hydraulic fluid being contained only in said hydraulic system, and in that the resilient member and the hydraulic system are two separate modules.
A composite fan blade root (300, 500, 600) comprising: an outer region (310, 610) comprising composite material and defining an outer inspection surface (320, 520, 620) of the component; and an internal reflection boundary (302, 502, 602) embedded within the root, the internal reflection boundary being configured to change a velocity of an ultrasonic signal emitted into the root from the inspection surface; the fan blade root further comprises an inner region (308, 608) surrounded by the outer region; characterised in that the boundary is in the form of a discontinuous layer of boundary material which delimits the inner region from the outer region and which has different acoustic properties from, and is embedded within, a composite material forming at least the outer region; and wherein the boundary is defined by a plurality of discrete portions of boundary material (306, 603). an outer region (310, 610) comprising composite material and defining an outer inspection surface (320, 520, 620) of the component; and an internal reflection boundary (302, 502, 602) embedded within the root, the internal reflection boundary being configured to change a velocity of an ultrasonic signal emitted into the root from the inspection surface; the fan blade root further comprises an inner region (308, 608) surrounded by the outer region; characterised in that the boundary is in the form of a discontinuous layer of boundary material which delimits the inner region from the outer region and which has different acoustic properties from, and is embedded within, a composite material forming at least the outer region; and wherein the boundary is defined by a plurality of discrete portions of boundary material (306, 603).
A compound of formula, or a pharmaceutically acceptable salt thereof, Or a tautomer thereof wherein: R 1 is alkyl, O-alkyl, Cl, F or Br; R 2 is H or F; R 3 is selected from H and alkyl; R 4 is selected from H and C R 6; R 5 is H; or R 4 and R 5 are linked to form a 5 to 6 membered saturated or unsaturated heterocyclic group optionally comprising 1 or 2 heteroatoms such as N, in addition to the N atoms to which R 4 and R 5 are bound, and where said heterocyclic group is optionally substituted with one or more R 10 groups; R 6 is selected from R 7, OR 7 and NR 8 R 9; R 7, R 8 and R 9 are each independently selected from alkyl, cycloalkyl, aralkyl, cycloalkenyl, heterocyclyl and aryl, each of which is optionally substituted with one or more R 10 groups; each R 10 is independently selected from halogen, OH, =O, CN, COO-alkyl, aralkyl, SO 2 -alkyl, SO 2 -aryl, COOH, CO-alkyl, CO-aryl, NH 2, NH-alkyl, N(alkyl) 2, CF 3, alkyl and alkoxy; X and Z are each independently CR 11, and Y is selected from CR 11 and N; R 11 is H, alkyl or F; for use in treating a disorder selected in the group of sepsis, systemic inflammatory response syndrome (SIRS), colitis, ulcerative colitis, Inflammatory Bowel Disease, diabetic nephropathy, hemorrhagic shock, spondylo-arthropathies, pancreatitis; inflammation-induced cancer; cystic fibrosis; polyglutamine diseases (such as Machado-Joseph disease); polyalanine diseases (such as oculo-pharyngeal muscular dystrophy); leukodystrophies and multiple sclerosis. R 1 is alkyl, O-alkyl, Cl, F or Br; R 2 is H or F; R 3 is selected from H and alkyl; R 4 is selected from H and C R 6; R 5 is H; or R 4 and R 5 are linked to form a 5 to 6 membered saturated or unsaturated heterocyclic group optionally comprising 1 or 2 heteroatoms such as N, in addition to the N atoms to which R 4 and R 5 are bound, and where said heterocyclic group is optionally substituted with one or more R 10 groups; R 6 is selected from R 7, OR 7 and NR 8 R 9; R 7, R 8 and R 9 are each independently selected from alkyl, cycloalkyl, aralkyl, cycloalkenyl, heterocyclyl and aryl, each of which is optionally substituted with one or more R 10 groups; each R 10 is independently selected from halogen, OH, =O, CN, COO-alkyl, aralkyl, SO 2 -alkyl, SO 2 -aryl, COOH, CO-alkyl, CO-aryl, NH 2, NH-alkyl, N(alkyl) 2, CF 3, alkyl and alkoxy; X and Z are each independently CR 11, and Y is selected from CR 11 and N; R 11 is H, alkyl or F; for use in treating a disorder selected in the group of sepsis, systemic inflammatory response syndrome (SIRS), colitis, ulcerative colitis, Inflammatory Bowel Disease, diabetic nephropathy, hemorrhagic shock, spondylo-arthropathies, pancreatitis; inflammation-induced cancer; cystic fibrosis; polyglutamine diseases (such as Machado-Joseph disease); polyalanine diseases (such as oculo-pharyngeal muscular dystrophy); leukodystrophies and multiple sclerosis.
A reservoir assembly for providing a cardioplegic solution, comprising a multi-chamber reservoir; a gas-impermeable outer package packaging the multi-chamber reservoir; and an oxygen detection agent and a deoxygenation agent in a space part between the multi-chamber reservoir and the outer package; wherein the deoxygenation agent neither generates nor absorbs carbon dioxide, wherein the multi-chamber reservoir comprises at least a first chamber, a second chamber, and a first separator wall that separates the two chambers, the first chamber holds a first medical liquid containing magnesium ions, the second chamber holds a second medical liquid containing bicarbonate ions, one or both of the first medical liquid and the second medical liquid contains potassium ions, the cardioplegic solution is obtainable by pressing one of the chambers so that the separator wall opens or peels off to allow mixing the first medical liquid and the second medical liquid, and the cardioplegic solution contains bicarbonate ions of 5 to 20 mEq/L, potassium ions of 10 to 35 mEq/L, and magnesium ions of 15 to 45 mEq/L. the multi-chamber reservoir comprises at least a first chamber, a second chamber, and a first separator wall that separates the two chambers, the first chamber holds a first medical liquid containing magnesium ions, the second chamber holds a second medical liquid containing bicarbonate ions, one or both of the first medical liquid and the second medical liquid contains potassium ions, the cardioplegic solution is obtainable by pressing one of the chambers so that the separator wall opens or peels off to allow mixing the first medical liquid and the second medical liquid, and the cardioplegic solution contains bicarbonate ions of 5 to 20 mEq/L, potassium ions of 10 to 35 mEq/L, and magnesium ions of 15 to 45 mEq/L.
A method of control channel detection for a wireless communication device, comprising the following steps: obtaining a time duration of a control region; determining whether a first control resource set is within the time duration; responsive to a determination that the first control resource set is within the time duration, detecting a control channel in the first control resource set, characterized by the subsequent steps of: determining whether a second control resource set is within the time duration; and responsive to a determination that the second control resource set is within the time duration, detecting the control channel in the second control resource set. obtaining a time duration of a control region; determining whether a first control resource set is within the time duration; responsive to a determination that the first control resource set is within the time duration, detecting a control channel in the first control resource set, characterized by the subsequent steps of: determining whether a second control resource set is within the time duration; and responsive to a determination that the second control resource set is within the time duration, detecting the control channel in the second control resource set. determining whether a second control resource set is within the time duration; and responsive to a determination that the second control resource set is within the time duration, detecting the control channel in the second control resource set.
A recombinant DNA molecule comprising a DNA sequence selected from the group consisting of: a) a sequence with at least 95 percent sequence identity to the full length of SEQ ID NO:2, wherein the DNA sequence has the same or similar promoter activity as SEQ ID NO:2; b) a sequence with at least 97 percent sequence identity to the full length of SEQ ID NO:1, 4, 5, or 7, wherein the DNA sequence has the same or similar gene-regulatory activity as respectively SEQ ID NO:1, 4, 5, or 7; c) a sequence comprising any of SEQ ID NOs:1, 2, 4, 5, and 7; and d) a fragment of any of SEQ ID NOs:1, 2, 4, 5, and 7, wherein the fragment has the same or similar gene-regulatory activity as respectively SEQ ID NOs:1, 2, 4, 5, and 7; wherein said sequence is operably linked to a heterologous transcribable DNA molecule. a) a sequence with at least 95 percent sequence identity to the full length of SEQ ID NO:2, wherein the DNA sequence has the same or similar promoter activity as SEQ ID NO:2; b) a sequence with at least 97 percent sequence identity to the full length of SEQ ID NO:1, 4, 5, or 7, wherein the DNA sequence has the same or similar gene-regulatory activity as respectively SEQ ID NO:1, 4, 5, or 7; c) a sequence comprising any of SEQ ID NOs:1, 2, 4, 5, and 7; and d) a fragment of any of SEQ ID NOs:1, 2, 4, 5, and 7, wherein the fragment has the same or similar gene-regulatory activity as respectively SEQ ID NOs:1, 2, 4, 5, and 7;
Track lighting system, mit: two track half-shells which, on an inner side along a longitudinal extension, are formed with a first socket on a first mounting edge and a second socket on a second mounting edge and furthermore are each formed with an electrical supply track between the first socket and the second socket along the longitudinal extension; at least one half-shell connector to connect the two track half-shells to form a mounting track which can be loaded from both sides, wherein the half-shell connector to connect the two track half-shells facing each other on the inside to the first socket or second socket located opposite each other is formed so that it can be equipped selectively along the longitudinal extension, wherein the connection of the two track half-shells with the half-shell connector creates a first mounting slot between the first mounting edges and a second mounting slot between the second mounting edges along the longitudinal extension of the track half-shells; and at least one light adapter, which is formed so that it can be inserted selectively along the longitudinal extension into the mounting slots (9a, 9b) in such a way that the light adapter protrudes through the respective mounting slot (9a, 9b) between the supply tracks when it is plugged in and is in electrical contact with the supply tracks. two track half-shells which, on an inner side along a longitudinal extension, are formed with a first socket on a first mounting edge and a second socket on a second mounting edge and furthermore are each formed with an electrical supply track between the first socket and the second socket along the longitudinal extension; at least one half-shell connector to connect the two track half-shells to form a mounting track which can be loaded from both sides, wherein the half-shell connector to connect the two track half-shells facing each other on the inside to the first socket or second socket located opposite each other is formed so that it can be equipped selectively along the longitudinal extension, wherein the connection of the two track half-shells with the half-shell connector creates a first mounting slot between the first mounting edges and a second mounting slot between the second mounting edges along the longitudinal extension of the track half-shells; and at least one light adapter, which is formed so that it can be inserted selectively along the longitudinal extension into the mounting slots (9a, 9b) in such a way that the light adapter protrudes through the respective mounting slot (9a, 9b) between the supply tracks when it is plugged in and is in electrical contact with the supply tracks.
A straddle-type vehicle comprising: at least one front wheel; at least one rear wheel; a driving source for generating a driving force and rotating the rear wheel with the driving force; a braking device for lowering a rotation speed of at least the rear wheel; a first detector for acquiring and outputting a pitch rate; a second detector for detecting and outputting information concerning rotation of the front wheel; and a controller including a front wheel lift determination section which monitors respective outputs from the first detector and the second detector to determine whether a front wheel lift exists or not based on the pitch rate and/or the information concerning rotation of the front wheel, the controller controlling or adjusting the driving source and/or the braking device when it is determined that a front wheel lift exists, the vehicle is characterized in that the first detector further acquires a bank angle and a yaw rate of the vehicle, and the pitch rate is corrected by using the bank angle and the yaw rate. at least one front wheel; at least one rear wheel; a driving source for generating a driving force and rotating the rear wheel with the driving force; a braking device for lowering a rotation speed of at least the rear wheel; a first detector for acquiring and outputting a pitch rate; a second detector for detecting and outputting information concerning rotation of the front wheel; and a controller including a front wheel lift determination section which monitors respective outputs from the first detector and the second detector to determine whether a front wheel lift exists or not based on the pitch rate and/or the information concerning rotation of the front wheel, the controller controlling or adjusting the driving source and/or the braking device when it is determined that a front wheel lift exists, the vehicle is characterized in that the first detector further acquires a bank angle and a yaw rate of the vehicle, and the pitch rate is corrected by using the bank angle and the yaw rate.
A mixed amino acid metal salt 1:1 complex of the mixed amino acid moieties lysine and glutamic acid of the formula: wherein M is a metal ion selected from the group consisting of iron, manganese, copper and zinc, (a) and (b) are numbers selected so the ratio of LYS:GLU is within the range of 40:60 to 60:40, and X is an anion selected to balance the metal ion charge.
A hybrid metal-composite drive shaft unit for power transmission in a rotary-wing aircraft, said hybrid metal-composite drive shaft unit comprising at least one metal drive shaft connector that is at least partly embedded into a composite drive shaft, said composite drive shaft comprising a thermoplastic polymer and being welded to said at least one metal drive shaft connector, wherein a welded connection is provided that defines a first load path for transmission of loads between said at least one metal drive shaft connector and said composite drive shaft, said at least one metal drive shaft connector and said composite drive shaft comprising, in the region of said welded connection, at least partly a polygonal cross-sectional shape for forming a form-fit connection that defines a second load path for transmission of loads between said composite drive shaft and said at least one metal drive shaft connector.
A process for preparing an antimicrobial particulate composition the process comprising the steps of: i. mixing an aqueous dispersion of an immobiliser, wherein the immobiliser is present in an amount of 1-5 wt% (by weight of the dispersion) and wherein the immobilizer is selected from inorganic porous material selected from zinc oxide, magnesium hydroxide or calcium carbonate and wherein the immobiliser has a particle size in the range of 1-10 microns and an aqueous solution of a reducing agent, wherein the reducing agent is present in the aqueous solution in an amount of from 10 to 30 wt% (by weight of the immobilizer in the aqueous despersion); ii. raising the temperature of the mixture resulting from step (i) to a temperature in the range 70° C to 90°C; iii. adding a water soluble metal salt to the mixture resulting from step (ii) in an amount equivalent to 0.05 to 3% of the metal by weight the immobilizer under mixing. i. mixing an aqueous dispersion of an immobiliser, wherein the immobiliser is present in an amount of 1-5 wt% (by weight of the dispersion) and wherein the immobilizer is selected from inorganic porous material selected from zinc oxide, magnesium hydroxide or calcium carbonate and wherein the immobiliser has a particle size in the range of 1-10 microns and an aqueous solution of a reducing agent, wherein the reducing agent is present in the aqueous solution in an amount of from 10 to 30 wt% (by weight of the immobilizer in the aqueous despersion); ii. raising the temperature of the mixture resulting from step (i) to a temperature in the range 70° C to 90°C; iii. adding a water soluble metal salt to the mixture resulting from step (ii) in an amount equivalent to 0.05 to 3% of the metal by weight the immobilizer under mixing.
A vulcanized tire manufacturing method comprising: vulcanizing a green tire in a vulcanization vessel for tire vulcanization; and sucking out gas from inside the vulcanization vessel at least after the vulcanization vessel has been opened. vulcanizing a green tire in a vulcanization vessel for tire vulcanization; and sucking out gas from inside the vulcanization vessel at least after the vulcanization vessel has been opened.